Rundu Pharmaceutical (002923.SZ) receives marketing approval for mosapride citrate API

Zhito Finance APP News: Rundu Pharmaceutical (002923.SZ) announced that the company recently received the "Marketing Application Approval Notice for Chemical Active Pharmaceutical Ingredients" for Mosapride Citrate issued by the National Medical Products Administration. The receipt of this marketing approval notice for Mosapride Citrate API further improves the company's product layout in the digestive field, enriches its product matrix, helps enhance overall market competitiveness, and aligns with the company's development strategy.